World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
109015
World Ranking
3143
National Ranking
1737

Research.com Recognitions

  • 1994 - Fellow of the American Statistical Association (ASA)

Overview

James D. Neaton is affiliated with the University of Minnesota in the United States. Their research primarily focuses on Medicine, with a notable emphasis on Infectious Diseases, Virology, and Epidemiology, as well as contributions to Neurology and Molecular Biology. The scientist's work encompasses a broad range of topics related to viral infections and treatments.

Neaton has published extensively on subjects including COVID-19 Clinical Research Studies, HIV Research and Treatment, and Viral Infections and Outbreaks Research. The following main topics have been a consistent part of their research portfolio:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Viral Infections and Outbreaks Research
  • Long-Term Effects of COVID-19
  • HIV/AIDS drug development and treatment
  • Viral Infections and Vectors

The scientist's recent published papers include:

  • Remdesivir for the Treatment of Covid-19 - Final Report, 2020, New England Journal of Medicine
  • A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19, 2020, New England Journal of Medicine
  • Randomized Trial of Vaccines for Zaire Ebola Virus Disease, 2022, New England Journal of Medicine
  • The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19, 2022, Annals of Internal Medicine
  • Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3), 2021, Clinical Trials

Frequent co-authors collaborating with James D. Neaton include:

  • H. Clifford Lane
  • Jens Lundgren
  • Virginia L. Kan
  • Elizabeth S. Higgs
  • Abdel G. Babiker

Neaton's work has been published predominantly in several scientific journals. The main publication venues are:

  • New England Journal of Medicine
  • AIDS
  • JCI Insight
  • PLoS ONE
  • Trials

In 1994, James D. Neaton was recognized as a Fellow of the American Statistical Association (ASA).

Best Publications

  • Remdesivir for the Treatment of Covid-19 - Final Report.

    John H. Beigel;Kay M. Tomashek;Lori E. Dodd;Aneesh K. Mehta

  • Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

    Jeremiah Stamler;Olga Vaccaro;James D. Neaton;Deborah Wentworth

  • Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

    Bertram Pitt;Willem Remme;Faiez Zannad;James Neaton

  • Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

    S Macmahon;R Peto;J E Cutler;R Collins

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

    D. J. Gordon;J. L. Probstfield;R. J. Garrison;Jim Neaton

  • Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

    Jeremiah Stamler;Deborah Wentworth;James D. Neaton

  • CD4+ count-guided interruption of antiretroviral treatment.

    Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin

  • Initiation of antiretroviral therapy in early asymptomatic HIV infection

    Sean Emery;Shweta Sharma;Gerd Fätkenheuer;Josep M. Llibre

  • Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

    Bertram Pitt;Philip A Poole-Wilson;Robert Segal;Felipe A Martinez

  • Blood Pressure and End-Stage Renal Disease in Men

    Michael J. Klag;Paul K. Whelton;Bryan L. Randall;James D. Neaton

  • Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

    Lewis H Kuller;Russell Tracy;Waldo Belloso;Stephane De Wit

  • Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data

    Jeremiah Stamler;Rose Stamler;James D. Neaton

  • The Prevention and Treatment of Missing Data in Clinical Trials

    Roderick J. Little;Ralph D'Agostino;Michael L. Cohen;Kay Dickersin

  • Treatment of Mild Hypertension Study: Final Results

    J D Neaton;R H Grimm;R J Prineas;J Stamler

  • Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

    Hiroyasu Iso;David R. Jacobs;Deborah Wentworth;James D. Neaton

  • Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events

    Philip Greenland;Maria Deloria Knoll;Jeremiah Stamler;James D. Neaton

  • Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

    Netanya Sandler;Handan Wand;Annelys Roque;Matthew G Law

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality.: A collaborative meta-analysis of high-risk population cohorts

    Marije van der Velde;Kunihiro Matsushita;Josef Coresh;Brad C. Astor

  • Blood pressure, systolic and diastolic, and cardiovascular risks

    Jeremiah Stamler;Rose Stamler;Jim Neaton

Frequent Co-Authors

Jeremiah Stamler
Jeremiah Stamler Northwestern University
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Richard H. Grimm
Richard H. Grimm University of Minnesota
Lewis H. Kuller
Lewis H. Kuller University of Pittsburgh
H. Clifford Lane
H. Clifford Lane National Institute of Allergy and Infectious Diseases
Ronald J. Prineas
Ronald J. Prineas Wake Forest University
Sean Emery
Sean Emery University of New South Wales
Andrew N. Phillips
Andrew N. Phillips University College London
Donald I. Abrams
Donald I. Abrams University of California, San Francisco
David R. Jacobs
David R. Jacobs University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their medical career options, a growing number of flexible online degrees can help you enter or advance within healthcare fields. Beyond traditional medicine, there is strong demand for professionals with leadership and management skills. Earning health administration degrees online can open doors to roles in hospital administration, patient services, and healthcare operations.

For those seeking higher-level opportunities, many universities now offer online mha programs affordable enough for working professionals. These programs provide advanced training in policy, finance, and healthcare leadership. Similarly, nurses can elevate their practice and earning potential by pursuing the cheapest dnp online programs, earning a Doctor of Nursing Practice without relocating or pausing their careers.

Pharmacists aiming to accelerate their education can now consider a 3 year online pharmd to obtain a Doctor of Pharmacy degree in less time. As healthcare evolves, these online pathway programs offer both flexibility and new career options for those studying medicine in the USA.

Best Scientists Citing James D. Neaton

Trending Scientists

Recently Published Articles